We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATIP
3001
DELISTED
ATI Physical Therapy, Inc.
ATIP
| $323K | ﹤0.01% |
6,462
-204
| -3% | -$11.6K |
|
3002
Cognyte Software
CGNT
$680M
| $317K | ﹤0.01% |
78,481
| – | – |
|
3003
1stdibs.com
DIBS
$171M
| $314K | ﹤0.01% |
49,921
+1,387
| +3% | +$8.98K |
|
|
HLVX
3004
DELISTED
HilleVax
HLVX
| $314K | ﹤0.01% |
18,369
| – | – |
|
3005
Spire Global
SPIR
$555M
| $311K | ﹤0.01% |
35,996
+818
| +2% | +$8.87K |
|
3006
Blue Bird Corp
BLBD
$2.18B
| $310K | ﹤0.01% |
37,142
| – | – |
|
3007
Duluth Holdings
DLTH
$159M
| $308K | ﹤0.01% |
43,724
-1,419
| -3% | -$12.7K |
|
|
ML
3008
DELISTED
MoneyLion Inc.
ML
| $308K | ﹤0.01% |
11,510
-1,626
| -12% | -$74.6K |
|
3009
Vodafone
VOD
$37.4B
| $306K | ﹤0.01% |
27,000
-49,800
| -65% | -$695K |
|
3010
IBEX
IBEX
$499M
| $302K | ﹤0.01% |
16,277
-2,254
| -12% | -$39.5K |
|
3011
Lifetime Brands
LCUT
$210M
| $302K | ﹤0.01% |
44,721
+1,116
| +3% | +$10.6K |
|
|
FXLV
3012
DELISTED
F45 Training Holdings Inc.
FXLV
| $302K | ﹤0.01% |
97,629
-17,253
| -15% | -$45.5K |
|
3013
Gaotu Techedu
GOTU
$436M
| $298K | ﹤0.01% |
246,300
+87,200
| +55% | +$141K |
|
|
WHWK
3014
Whitehawk Therapeutics
WHWK
$235M
| $296K | ﹤0.01% |
20,913
| – | – |
|
|
JOAN
3015
DELISTED
JOANN, Inc. Common Stock
JOAN
| $296K | ﹤0.01% |
44,704
-11,306
| -20% | -$96.7K |
|
|
NBP
3016
NovaBridge Biosciences American Depositary Shares
NBP
$202M
| $290K | ﹤0.01% |
72,200
+19,900
| +38% | +$151K |
|
|
PARAA
3017
DELISTED
Paramount Global Class A
PARAA
| $289K | ﹤0.01% |
13,435
-7,564
| -36% | -$204K |
|
3018
Bakkt Inc
BKKT
$337M
| $288K | ﹤0.01% |
5,052
-25
| -0.5% | -$1.67K |
|
3019
Global Water Resources
GWRS
$219M
| $284K | ﹤0.01% |
24,245
| – | – |
|
3020
HighPeak Energy
HPK
$910M
| $284K | ﹤0.01% |
13,134
+119
| +0.9% | +$2.8K |
|
3021
NextNav
NN
$2.23B
| $283K | ﹤0.01% |
105,293
+35,880
| +52% | +$104K |
|
3022
Hydrofarm Holdings
HYFM
$7.62M
| $282K | ﹤0.01% |
14,507
-391
| -3% | -$12.6K |
|
|
EXPR
3023
DELISTED
Express, Inc.
EXPR
| $281K | ﹤0.01% |
12,929
-777
| -6% | -$26.5K |
|
3024
Humacyte
HUMA
$194M
| $280K | ﹤0.01% |
85,846
-3,766
| -4% | -$14.4K |
|
3025
Distribution Solutions Group
DSGR
$1.61B
| $279K | ﹤0.01% |
19,804
-11,486
| -37% | -$249K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.